Results 241 to 250 of about 352,265 (309)
Recent Advances in Targeted Therapies for Adult Gliomas. [PDF]
Lasica AB +4 more
europepmc +1 more source
Enhancing clinical insights in glioma grading using Bayesian Optimization and Explainable AI. [PDF]
Elsayad AM, Elsayad OA.
europepmc +1 more source
Triple-Targeted DNA Nanozyme Executes Disulfidptosis for Glioma Elimination. [PDF]
Wu T +7 more
europepmc +1 more source
Redefining the immune microenvironment of gliomas in the era of single-cell genomics. [PDF]
Gonzalez Castro LN +3 more
europepmc +1 more source
Tumor-suppressive role of miR-216b impacts cell cycle regulation in high-grade glioma. [PDF]
Lang A +34 more
europepmc +1 more source
Metabolic dependencies and neural progenitor dysregulation: driving forces in paediatric high-grade glioma development. [PDF]
Lee YHG +4 more
europepmc +1 more source
Some of the next articles are maybe not open access.
Related searches:
Related searches:
2023
This chapter provides a comprehensive overview of malignant gliomas, the most common primary brain tumor in adults. These tumors are varied in their cellular origin, genetic profile, and morphology under the microscope, but together they share some of the most dismal prognoses of all neoplasms in the body.
Linda M, Wang +3 more
openaire +2 more sources
This chapter provides a comprehensive overview of malignant gliomas, the most common primary brain tumor in adults. These tumors are varied in their cellular origin, genetic profile, and morphology under the microscope, but together they share some of the most dismal prognoses of all neoplasms in the body.
Linda M, Wang +3 more
openaire +2 more sources
Voprosy neirokhirurgii imeni N.N. Burdenko, 2022
The authors present 2 patients. One of them had typical multifocal primary multiple synchronous wild-type IDH1/2 glioblastoma subtype RTK1, chromosome 7 duplication, homozygous CDKN2A deletion and chromosome 10 deletion. In another patient, the nature of tumors remains debatable.
M.V. Ryzhova +6 more
openaire +2 more sources
The authors present 2 patients. One of them had typical multifocal primary multiple synchronous wild-type IDH1/2 glioblastoma subtype RTK1, chromosome 7 duplication, homozygous CDKN2A deletion and chromosome 10 deletion. In another patient, the nature of tumors remains debatable.
M.V. Ryzhova +6 more
openaire +2 more sources

